Newsfeeds Archive - Page 2 of 3

2 minute read

DiaMedica Therapeutics Provides A Business Update And Announces FY22 Financial Results; DiaMedica Reported Total Cash, Cash Equivalents And Investments Of $33.5M

March 28, 4:34 PM

Balance Sheet and Cash Flow DiaMedica reported total cash, cash equivalents and investments of $33.5 million, current liabilities of $2.2 million and working capital of $31.7 million as of

DMAC

4 minute read

Earnings

Earnings Scheduled For March 28, 2023

By Benzinga Insights

March 28, 6:38 AM

Companies Reporting Before The Bell • Futu Holdings (NASDAQ:FUTU) is expected to report quarterly earnings at $0.70 per share on revenue of $237.12 million.

AADI

1 minute read

Earnings

DiaMedica Therapeutics’s Earnings Outlook

By Benzinga Insights

March 27, 12:02 PM

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Tuesday, 2023-03-28. Here’s what investors…

DMAC

2 minute read

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying

By Lisa Levin

December 2, 9:43 AM

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BTN

9 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

November 7, 1:47 PM

On Monday, 160 companies hit new 52-week lows.

$APE

5 minute read

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday

By Lisa Levin

October 28, 4:57 AM

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.

AAN

5 minute read

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

October 7, 6:29 AM

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

AGEN

1 minute read

Earnings

DiaMedica Therapeutics: Q2 Earnings Insights

By Benzinga Insights

August 10, 11:28 PM

DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

DMAC

1 minute read

DiaMedica Therapeutics Q2 EPS $(0.13) Beats $(0.18) Estimate

By Michael Horton

August 10, 5:21 PM

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share

DMAC

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

August 10, 11:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP